Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Inflammatory Carcinoma”

133 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 133 results

Not applicableUnknownNCT00005058
What this trial is testing

Enhanced Ultrasound in Determining Extent of Disease in Women With Primary Breast Cancer

Who this might be right for
Breast Cancer
Royal Marsden NHS Foundation Trust
Testing effectiveness (Phase 2)Study completedNCT01325428
What this trial is testing

Afatinib (BIBW2992) in HER2 (Human Epidermal Growth Factor Receptor 2)-Overexpressing Inflammatory Breast Cancer

Who this might be right for
Breast Neoplasms
Boehringer Ingelheim 26
Testing effectiveness (Phase 2)Study completedNCT00096343
What this trial is testing

Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
University of Alabama at Birmingham 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT03515798
What this trial is testing

Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast Cancer

Who this might be right for
Inflammatory Breast Cancer
Institut Paoli-Calmettes 52
Testing effectiveness (Phase 2)Study completedNCT02556632
What this trial is testing

Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer

Who this might be right for
Breast CarcinomaPainRadiation-Induced Dermatitis+1 more
Gary Morrow 191
Very early researchStudy completedNCT01894451
What this trial is testing

Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy

Who this might be right for
Inflammatory Breast Carcinoma
Dana-Farber Cancer Institute 2
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT02041429
What this trial is testing

Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory Brca

Who this might be right for
Recurrent Breast CancerMetastatic Breast Cancer
Dana-Farber Cancer Institute 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03012100
What this trial is testing

Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer

Who this might be right for
Bilateral Breast CarcinomaBreast Inflammatory CarcinomaStage IB Breast Cancer AJCC v7+9 more
Academic and Community Cancer Research United 280
Large-scale testing (Phase 3)UnknownNCT02879513
What this trial is testing

Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy

Who this might be right for
Invasive Ductal Breast CancerTubular Breast CancerMucinous Breast Cancer+1 more
RenJi Hospital 290
Testing effectiveness (Phase 2)Ended earlyNCT03184558
What this trial is testing

Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBC

Who this might be right for
Triple Negative Breast CancerInflammatory Breast Cancer Stage IV
BerGenBio ASA 29
Large-scale testing (Phase 3)WithdrawnNCT00397761
What this trial is testing

Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Medstar Health Research Institute
Testing effectiveness (Phase 2)Study completedNCT01262027
What this trial is testing

TKI258 for Metastatic Inflammatory Breast Cancer Patients

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 22
Large-scale testing (Phase 3)Study completedNCT05415215
What this trial is testing

Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer

Who this might be right for
Early Breast CancerLocally Advanced Breast CancerInflammatory Breast Cancer
Hoffmann-La Roche 346
Not applicableLooking for participantsNCT04636710
What this trial is testing

Refining Local-Regional Therapy for IBC

Who this might be right for
Breast CancerInflammatory Breast CancerSentinel Lymph Node
Dana-Farber Cancer Institute 50
Testing effectiveness (Phase 2)Study completedNCT00558103
What this trial is testing

Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 163
Early research (Phase 1)Ended earlyNCT00004261
What this trial is testing

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

Who this might be right for
Breast CancerCervical CancerHead and Neck Cancer+2 more
University Health Network, Toronto
Testing effectiveness (Phase 2)Ended earlyNCT05041101
What this trial is testing

Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer

Who this might be right for
Breast Inflammatory CarcinomaRecurrent Breast Inflammatory CarcinomaStage IV Breast Inflammatory Carcinoma
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00070252
What this trial is testing

Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer

Who this might be right for
Adult Solid NeoplasmInflammatory Breast CarcinomaMale Breast Carcinoma+2 more
National Cancer Institute (NCI) 53
Testing effectiveness (Phase 2)Study completedNCT00193050
What this trial is testing

Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
SCRI Development Innovations, LLC 110
Load More Results